National Center of Excellence for Pharmaceutical Process Design to be Established in the U.S.
Onshoring this capability will enable faster pharma response times and fewer supply chain disruptions.
Edited by Margo Ellis

The Mid-Atlantic Technology, Research & Innovation Center (MATRIC) announced it will establish the Center of Excellence (CoE) for process design, defining a new standardized process development framework to streamline chemical manufacturing processes from laboratory bench through to commercial production. The initial projects will develop continuous processes for critical materials for the pharmaceutical industry currently substantially produced overseas. These new capabilities will be established as a result of the Department of Commerce’s recent Rapid Assistance (for) Coronavirus Economic Response (RACER) grant to the RAPID Manufacturing Institute, of which MATRIC is a sub-awardee.
“Today, the U.S. doesn’t have the manufacturing capability to produce some key raw materials and intermediates at scale to support our pharmaceutical industry and needs,” said MATRIC chairman and CEO Steven B. Hedrick. “The COVID pandemic and the current global supply chain issues have taught us the importance of supply chain stability and security, and this starts with critical raw materials produced domestically, distributed with purpose and efficiently accessed.” Read the complete article here.
RELATED CONTENT
-
The Basics of Eccentric Plug Valves
Wastewater systems present many challenges to pumps and valves because the flow can contain grit, solids and debris, depending where in the process the equipment is located.
-
Paint & Coatings
A walk through a typical valve distributor’s warehouse will yield a contrasting view of either silver or black products.
-
The Diverse Role Valves Play in the Chemical Industry
The chemical industry is extremely diverse with more than 60,000 known products. Like all process industries, the chemical industry needs valves designed for safe, efficient and reliable process operation.